Usana Health Sciences market cap USNA
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $272M
- Highest close in our data
- $3.2B
- Aug 2018
Usana Health Sciences is worth $272M at the close on Nov 2, 2026, at $14.72 a share.
That is down 22% over the last year and down 87% over five years.
Its highest close in our data was $3.2B in Aug 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $272M | $247M | $411.9M | −25% |
| 2025 | $362.7M | $349.7M | $689.4M | −47% |
| 2024 | $680.2M | $636.2M | $973.5M | −34% |
| 2023 | $1B | $866M | $1.3B | +0% |
| 2022 | $1B | $963.8M | $2B | −48% |
| 2021 | $2B | $1.7B | $2.1B | +21% |
| 2020 | $1.6B | $1B | $1.9B | −6% |
| 2019 | $1.7B | $1.4B | $2.9B | −37% |
| 2018 | $2.8B | $1.8B | $3.2B | +55% |
| 2017 | $1.8B | $696.9M | $1.8B | +138% |
| 2016 | $746.2M | $731M | $1.8B | −54% |
| 2015 | $1.6B | $1.2B | $2.1B | +28% |
| 2014 | $1.3B | $809.3M | $1.5B | +18% |
| 2013 | $1.1B | $500.3M | $1.2B | +137% |
| 2012 | $455.9M | $455.9M | $707.2M | +0% |
| 2011 | $454.3M | $355.9M | $527.6M | n/a |
Against its peers
Companies in Chemicals nearest Usana Health Sciences' size, closest first, today.
| Company | Market cap |
|---|---|
| USNAUsana Health Sciences | $272M |
| NAGENiagen Bioscience | $189.9M |
| FTKFlotek Industries | $850.1M |
| FTLFFitlife Brands | $75.4M |
| CRONCronos | $1.2B |
| BTMDbiote | $40.6M |
| ROGRogers | $2.3B |
| IOSPInnospec | $2.5B |
| NGVTIngevity | $2.5B |
| Peer median | $1B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Usana Health Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.